Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

AIDS/syringe exchange study

07.11.2002


Drug users with access to controversial syringe-exchange programs are up to six times less likely to put themselves at risk of HIV infection, according to a new UC Davis study published in the November issue of Journal of Acquired Immune Deficiency Syndromes.



"While programs to control the spread of HIV by providing clean needles to drug users remain controversial in California and around the country, this study clearly shows that syringe-exchange programs save lives -- and save society millions of dollars in health care costs required to treat HIV patients," said lead author David R. Gibson, associate professor of infectious and immunologic diseases at UC Davis and a senior scientist at UC San Francisco’s Center for AIDS Prevention Studies.

Injection drug use is linked to about one-third of all HIV/AIDS cases, according to the Centers for Disease Control and Prevention. Drug users contract these diseases by sharing contaminated syringes. To curb this high-risk behavior, syringe exchanges operate in a variety of settings, including storefronts, vans, sidewalk tables, health clinics, and places where drug users gather.


The first organized syringe-exchange programs in the United States were established in the late 1980s, despite strong opposition from some communities on moral grounds -- opposition that continues today.

"While this study should open the way to a more fact-based discussion of these controversial programs, a small, vocal minority simply refuses to look at the scientific evidence -- they are essentially ’data-proof,’" Gibson said.

The UC Davis study offers the most detailed examination to date of the complex factors of the role of syringe exchanges in reducing HIV risk behavior, Gibson said. The study addressed several key challenges that have tended to distort the findings of previous syringe-exchange studies, he added.

For instance, the study did a better job than previous studies had done in correcting for pre-existing differences between injecting drug users who seek to use a syringe-exchange program compared with those that do not. In addition, the study controlled for other sources of syringes that drug users may have and compared drug users who had other sources of syringes with those without other sources.

To adjust for these factors, the UC Davis researchers adopted more rigorous statistical controls than previous studies.

Among injecting drug users who already have some access to clean syringes, a syringe-exchange program results in a two-fold reduction in HIV risk behavior, said Gibson. For drug users with no other easy access to clean syringes, the benefits are even more significant -- a six-fold reduction in risk behaviors. Syringe-exchange programs will naturally appear less effective in communities with multiple sources of clean syringes compared to programs that constitute a community’s only supply.

"These findings underscore just how critical syringe exchange may be for all injecting drug users, but especially those who lack the resources or contacts to obtain syringes in other ways," said Gibson. "It also suggests syringe-exchange programs can be most effective in reducing HIV by focusing on getting sterile syringes to these most vulnerable drug users."

The findings are especially relevant in California in the wake of an intense debate over Senate Bill 1785, which would have allowed pharmacies to sell syringes to adults without a prescription. Gov. Gray Davis vetoed the bill in late September because it did not require a one-to-one needle exchange. Without this provision, Gov. Davis said, the bill could increase the number of contaminated needles and syringes in parks, beaches, and other public areas.

"Without access to clean syringes through pharmacies, injecting drug users must continue to rely on exchange programs to avoid high-risk behavior and curb the spread of HIV," said Gibson.

The study followed a group of 259 untreated injecting drug users in the San Jose area. Each of the participants was interviewed at the beginning of the study and then participated in follow-up interviews -- an average of about 11 months later. Some of the participants were clients of the San Jose syringe exchange, which used a mobile van to visit five sites frequented by injecting drug users.

The new study builds on a July 2001 UC Davis study, also lead by Gibson, which reviewed 42 studies on syringe-exchange programs from the United States, Canada, the United Kingdom and the Netherlands. The study concluded that previous studies often underestimated the effectiveness of syringe-exchange programs in communities where clean needles can be easily obtained from sources other than the syringe exchange. In addition, researchers have found that in areas where drug users have a choice between syringe exchange and legally obtaining syringes from pharmacies, the higher-risk users tend to gravitate to syringe-exchange programs. As a result, the syringe exchanges appear less effective when users of syringe exchange are compared with nonusers.

The first organized syringe-exchange programs in the United States were established in Tacoma, Washington; Portland, Oregon; San Francisco; and New York City. By 1997, there were 113 programs in more than 30 states, the District of Columbia, and Puerto Rico, which exchanged more than 17 million syringes, according to the Centers for Disease Control and Prevention.


###
Research was funded with a grant from the National Institute on Drug Abuse, United States Public Health Service.


Carole Gan | EurekAlert!
Further information:
http://www.ucdmc.ucdavis.edu/medical_center/index

More articles from Health and Medicine:

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

Decoding cement's shape promises greener concrete

08.12.2016 | Materials Sciences

Will Earth still exist 5 billion years from now?

08.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>